Search
for

    Sort by

    Research 451–480 of 1000+

    1. NEW FORMULATIONS: Sodium cromoglycate Australian Prescriber · 2004
    2. NEW PROPRIETARY BRANDS: Cefaclor monohydrate Australian Prescriber · 2004
    3. NEW FORMULATIONS: Glatiramer acetate Australian Prescriber · 2004
    4. Drug Therapy in Polycystic Ovarian Syndrome Aap Grand Rounds · 2003
    5. Risk of Abnormal Pregnancy Completing Chemotherapy for Gestational Trophoblastic Tumor Obstetrical & Gynecological Survey · 2003
    6. Polycystic ovary syndrome [PCOS]: Comprehensive management in primary care Comprehensive Therapy · 2002
    7. Hirsutism 2002
    8. Current best evidence in pigmentary dermatology Pigment International · 2024
    9. Do Pleiotropic Effects of Spironolactone in Women with PCOS make it More Than an Anti-Androgen? Evidence from a Systematic Review and Meta-Analysis Current Pharmaceutical Design · 2023
    10. Update on Hormonal Therapy in Hidradenitis Suppurativa Journal of Drugs in Dermatology · 2023
    11. The Clinical Manifestations of Polycystic Ovary Syndrome (PCOS) and The Treatment Options European journal of biology and medical science research · 2023
    12. Diagnosis and Treatment of PCOS- A Comparative Review International journal of pharmaceutical sciences review and research · 2022
    13. The role of correction of metabolic disorders in the treatment of androgenetic alopecia in women Rossiiskii Zhurnal Kozhnykh i Venericheskikh Boleznei · 2016
    14. Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action Heliyon · 2024 · 2 citations
    15. A Systematic Review of Endocrine Therapy for Improved Reproductive and Metabolic Outcomes in PCOS Women Pediomaternal Nursing Journal · 2021
    16. New drugs: Agalsidase alfa Australian Prescriber · 2004
    17. Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials EClinicalMedicine · 2023 · 7 citations
    18. Dermatologic Implications of Glycemic Control Medications for Patients with Type 2 Diabetes Mellitus Cutis · 2025 · 2 citations
    19. PD35-08 ASSOCIATION OF COMMON MEDICATION WITH PROSTATE-SPECIFIC ANTIGEN LEVEL IN 45-YEAR-OLD GERMAN MEN: RESULTS OF THE PROBASE TRIAL The Journal of Urology · 2019
    20. Drug Repurposing: Expanding Therapeutic Potential of Existing Drugs ˜The œBioscan. · 2026
    21. NGHIÊN CỨU TÁC DỤNG HẠ ĐƯỜNG HUYẾT CỦA CAO CHIẾT HÀNH TÍM (ALLIUM ASCALONICUM L., ALLIACEAE) TRÊN MÔ HÌNH CHUỘT GÂY TĂNG ĐƯỜNG HUYẾT BẰNG ALLOXAN Tạp chí Y Dược học Cần Thơ · 2023
    22. Journal Watch Clinical and Experimental Dermatology · 2001
    23. Comparative advantage and efficacy of natural products for polycystic ovary syndrome Journal of Ovarian Research · 2025 · 4 citations
    24. Efficacy and safety of SGLT2 inhibitor on insulin resistance and hyperglycemia in Werner syndrome—A case report Journal of Diabetes Investigation · 2025
    25. Selected abstracts from the 47th meeting of the Irish Endocrine Society Sligo, 24th & 25th November 2023 Irish Journal of Medical Science (1971 -) · 2024
    26. MON-369 Treatment of Nonclassic 11-Hydroxylase Deficiency with "Hair, Skin, and Nails," an Over-the-Counter, Insulin Sensitizing Vitamin/Mineral Supplement Journal of the Endocrine Society · 2019
    27. Clin-Alert Clin-Alert · 2002
    28. Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics Journal of Clinical Medicine · 2023 · 380 citations
    29. Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions Frontiers in Endocrinology · 2020 · 138 citations
    30. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Hyperandrogenic Disorders Endocrine practice · 2001 · 89 citations